EMRL engages in new NIH-supported collaboration aimed at providing countermeasures against chemical threats

PI Douglas Feinstein is leading this effort to assess lipid emulsions as a countermeasure against superwarfarin poisonings.  The project brings together investigators in Medicine, Engineering, and Pharmacy at UIC. More information.

NIH CounterACT grant 1U01NS083457.